Tepotinib in patients with MET exon 14 (METex14) skipping advanced NSCLC: Updated efficacy results from VISION cohort A Meeting Abstract
| Authors: | Paik, P.; Sakai, H.; Felip, E.; Veillon, R.; Garassino, M. C.; Raskin, J.; Viteri, S.; Mazieres, J.; Cortot, A.; Smit, E.; Thomas, M.; Cho, B. C.; Conte, P.; Yang, J. C.; Morise, M.; Chen, Y.; Park, K.; Gottfried, M.; Britschgi, C.; Bruns, R.; Otto, G.; Johne, A.; Le, X. |
| Abstract Title: | Tepotinib in patients with MET exon 14 (METex14) skipping advanced NSCLC: Updated efficacy results from VISION cohort A |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | met inhibitor; tepotinib; met exon 14 skipping |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S174 |
| Language: | English |
| ACCESSION: | WOS:000631349600199 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.250 |
| Notes: | Meeting Abstract: MA11.05 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
